Food or edible material: processes – compositions – and products – Products per se – or processes of preparing or treating... – Nutritional or dietetic supplement – including table salt
Reexamination Certificate
2006-03-07
2006-03-07
Chan, Christina (Department: 1644)
Food or edible material: processes, compositions, and products
Products per se, or processes of preparing or treating...
Nutritional or dietetic supplement, including table salt
C435S007710, C514S473000
Reexamination Certificate
active
07008666
ABSTRACT:
The invention relates to a method of inhibiting myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan, where said lignan is enterolactone. The invention is further directed to a method inhibiting myeloperoxidase activity or oxidative burst of macrophages in an individual by administering to the individual an effective amount of a lignan where said lignan is enterolactone or hydroxymatairesinol or a mixture. Finally, the invention is directed to a method of inhibiting oxidative burst or myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan which is hydroxymatairesinol.
REFERENCES:
patent: 6451849 (2002-09-01), Ahotupa et al.
patent: 0 906 761 (1999-04-01), None
patent: WO 00/59946 (2000-10-01), None
patent: WO 02/080702 (2002-10-01), None
Pool-Zobel et al, Carcinogenesis 21(6): 1247-52, 2000.
The Merck manual, p. 420-421, 1999 edition.
Morikawa et al, J. Pharm Pharmacol 44(10): 859-61, Oct. 1992.
Yesilada et al, Cytokine 13(6): 359-364, Mar. 21, 2001.
Yesilada, E. et al. (2001). “In Vitro Inhibitory Effects ofDaphne OleoidesSSP.Oleoideson Inflammatory Cytokines and Activity-Guided Isolation of Active Constituents,”Cytokine13(6):359-364.
Cho, Jae Youl et al. (1999). “Immunomodulatory Effect of Arctigenin, a Lignan Compound, on Tumour Necrosis Factor-alpha and Nitric Oxide Production and Lymphocyte Proliferation,”J. Pharm. Pharmacol. 51:1267-1273.
Yang, Li-Ming et al. (1996). “Synthesis and Anti-HIV Actvity of Dibenzylbutyrolactone Lignans,”Bioorganic&Medicinal Chem. Letts. 6(8):941-944.
Cho, Min Kyung et al. (2002). “Potent Inhibition of Lipopolysaccharide-Inducible Nitric Oxide Synthase Expression by Dibenzylbutyrolactone Lignans Through Inhibition of I-κ Bα Phosphorylation and of p65 Nuclear Translocation in Macrophages,”Intl. Immunopharmacol. 2:105-116.
Hirano, Toshihiko et al. (1994). “Natural Flavonoids and Lignans are Potent Cytostatic Agents Against Human Leukemic HL-60 Cells,”Life Sciences55(13):1061-1069.
Ahotupa Markku
Eriksson John
Kangas Lauri
Komi Janne
Korte Helena
Chan Christina
Hormos Nutraceutical Oy Ltd.
Huynh Phuong
Rothwell Figg Ernst & Manbeck P.C.
LandOfFree
Method of inhibiting overactivity of phagocytes or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting overactivity of phagocytes or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting overactivity of phagocytes or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3582732